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Introduction
Heterotopic pregnancy (HP), defined as concomitant intrau-
terine and ectopic pregnancy, is a rare event. The overall rate 
of heterotopic pregnancies is about 1/30.000 in spontaneous 
pregnancies, while the rate in pregnancy due to assisted 
reproduction is 0.15%.1,2 Multiple factors may lead to the 
development of HP after assisted reproduction. Tubal abnor-
malities including scarring that may prevent the embryos’ 
return to the uterine cavity after the embryo transfer (ET), 
and the multiple number of embryos that may be transferred 
every cycle, represent the most significant factors. Other 
causes that may lead to embryo implantation in the fallopian 
tube include the misplacement of catheter tip, a wrong pres-
sure used to inject embryos, and endometrial bleeding due to 
traumatic ET procedure.3,4
Risk factors associated with heterotopic pregnancies are 
the same as ectopic ones: previous ectopic pregnancy, tubal 
or uterine abnormality, infertility treatment, previous pelvic 
inflammatory disease (PID), and previous tubal surgery.5 In 
HIV patients, several risk factors may be present. In fact, 
HIV is a sexually transmitted disease (STD) and conse-
quently is a risk factor for PID;6 moreover, recently, also 
HIV serodiscordant couples where the woman is positive 
had access to assisted reproductive programmes. Therefore, 
HIV infection could increase the risk of HP. We report the 
first case of HP occurred in a HIV-positive woman.
Case
A 30-year-old woman, gravida 3 para 1 with a previous 
spontaneous miscarriage, presented to our obstetric depart-
ment, demanding legal abortion. Her past medical history 
included HIV seropositivity, discovered 10 years before dur-
ing her previous pregnancy. The patient had begun highly 
active antiretroviral therapy (HAART) since the HIV diag-
nosis, with any manifestations HIV correlated. At the 
moment of our attention, her CD4 count was 250/mm3 and 
HIV-RNA was lower than 37 copies/mL. During her first 
obstetric visit, ultrasound evaluation confirmed the presence 
of a viable pregnancy in utero. The embryo had a crown–
rump length (CRL) of 1.6 cm, corresponding to 8 weeks, 
according to last menstrual period; her surgery was sched-
uled for the following week.
Five days after this first obstetric examination, patient 
arrived to our emergency department with acute symptoma-
tology: she had diffuse abdominal pain, and uterus and 
adnexal regions were aching at the mobilization; copious 
vaginal discharges, but not vaginal bleeding, were observed. 
Transvaginal ultrasonography confirmed again the gesta-
tional sac containing the yolk sac and a fetal pole of 1.8 cm in 
CRL and evidenced an irregular adnexal mass of 65 × 60 mm2 
with heterogeneous echogenicity near the left ovary; the right 
ovary was regular and corpus luteum was visible. Rectal tem-
perature was 37.2°C and temperature at arm-pit was 36.8°C. 
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White blood cell count was 7.03/mm3. Patient was hospital-
ized in our unit with the diagnosis of suspect PID or tubo-
ovarian abscess (TOA) and begun antibiotic therapy with 
clindamycin 600 mg × 3 times in a day. During shelter, patient 
underwent legal abortion and histological analysis confirmed 
the presence of intrauterine pregnancy. The successive ultra-
sound examination evidenced a reduction in dimension of 
adnexal mass (22 × 23 mm2), which appeared irregular and 
less strained, suggesting the diagnosis of TOA evidenced also 
by a positive response to therapy. Six days after the beginning 
of antibiotic therapy, the patient was dismissed with a diagno-
sis of TOA, according to the remission of painful symptoma-
tology after therapy.
One week after her discharge, the patient presented again 
to our emergency department complaining of abdominal 
pain associated to a lipotimic episode. Physical examination 
showed tenderness to palpation, with a positive Blumberg 
sign; vital signs were stable. Gynaecological examination 
evidenced pain at the uterus mobilization and revealed the 
presence of soft and aching tumefaction in the Douglas cav-
ity. Ultrasound scan showed a conspicuous amount of free 
fluid around the uterus and mainly concentrated in the 
Douglas space. No adnexal mass was found. According to 
clinical and laboratories values (reduction in haemoglobin 
from 7.8 mg/dL, at the time of previous hospital discharge, to 
6.8 mg/dL), she was transferred to the operatory room to per-
form an explorative laparoscopy. The laparoscopy demon-
strated a normal-sized uterus and normal ovaries. The 
ampulla and fimbriated end of the left fallopian tube were 
markedly distended and bleeding; the right fallopian tube 
was normal. Left salpingectomy was performed; estimated 
blood loss was 700 mL, therefore two units of packed red 
blood cells were transfused to correct anaemia. The left fal-
lopian tube was submitted to the pathology department and 
histological analysis confirmed the diagnosis of tubal 
pregnancy.
The postoperative course was uneventful, and the patient 
was discharged in a stable condition on Day 3 after surgery.
Discussion
HP is defined as concomitant intrauterine and ectopic preg-
nancies. This event is extremely rare and its rarity can com-
promise the possibility of diagnosis. However, in the presence 
of some particular patients, physicians should consider the 
possibility of this clinical evidence. We know that ectopic 
pregnancy is a major cause of morbidity and mortality in 
reproductive age women, accounting for 4.9% of pregnancy-
related deaths in developed countries and up to 10% in the first 
trimester of gestation.7–9 Higher rates of ectopic pregnancy 
have been reported in HIV-positive women than in uninfected 
women, problably due to associated STDs.10 Genital tract 
infections such as Neisseria gonorrhoeae, Chlamydia tra-
chomatis and Trichomonas vaginalis infections have been 
reported to be more common in women with HIV. In a cohort 
of 1215 women, of which 238 experienced seroconversion to 
HIV, there was a higher incidence of genital ulcer disease 
(genital herpes, syphilis, Chlamydia trachomatis; OR = 2.8), 
gonorrhoea (OR = 1.6) and trichomoniasis (OR = 1.3) among 
HIV seropositive women versus HIV seronegative women.11 
As a consequence, PID has a higher prevalence in HIV 
patients: even HIV women with acute PID more often fail 
medical therapy and require changes in it or surgical interven-
tion; in addition, HIV infection prolongs hospitalization in 
women with severe salpingitis.12 Also, the prevalence of TOA 
is higher in seropositive women than in seronegative ones 
(OR = 2.8), and this risk increases in a stepwise fashion with 
the decreasing CD4 cell counts.13
Hence, when an HIV patient presents to an emergency 
department complaining of acute abdominal pain, we have to 
suspect a PID, or a possible ectopic pregnancy or heterotopic 
one if the woman is pregnant. In our patient, the diagnosis of 
PID could be suggested by some clinical and laboratory cri-
teria. Several studies evidence that PID in HIV-positive 
women is characterized by low levels of white blood cell and 
lymphocytes count, absence of fever at admission, and high 
prevalence of TOAs.13–15 All these elements were found in 
our patient when she presented to our emergency depart-
ment, and the suspect of PID was confirmed by clinical 
response to antimicrobial therapy. In fact, on Day 6, after 
shelter, we observed the relief of the symptoms associated to 
normalization of laboratory findings. White blood cell count 
changed from 7.3/mm3 at enrolment to 5.8/mm3 on Day 6 of 
therapy. The adnexal mass was smaller compared to dimen-
sions at shelter (from 65.0 × 60.0 mm2 to 22.0 × 23.0 mm2). 
All these data were according to several studies that compare 
clinical course of PID in women infected and not infected by 
immunodeficiency virus.13–15 These authors evidence a simi-
lar response to therapy in HIV-infected women and a symp-
tomatical improvement in 2–4 days.
In conclusion, we report the first case of HP occurred 
spontaneously in a HIV-positive woman. This evidence can 
be important, suggesting a possible role of HIV infection in 
the clinical and laboratory’s manifestations of ectopic preg-
nancy, particularly if it is associated with a concomitant 
intrauterine pregnancy. It also suggests that HIV-seropositive 
women represent a specific category in which is necessary 
suspecting an ectopic pregnancy in addition to PID in case of 
acute abdomen and even a HP when there are findings of an 
ongoing intrauterine pregnancy.
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